Embed Size (px)
Citation preview
Demand for hemostatic solutions in Russia
Capacity of the market
50 – 70Bill. rub
30 000 hospitals and clinics13 600 ambulances
50 mill. cars
2 mill. officers
100 000 schools
Demand for hemostatic solutions in US and Europe
Capacity of the market United
States and Europe
1,2
bill. $GAGR = 9.4 %
Product
«Tectum» – hemostatic polymer composition
Key advantages
Stop bleeding within 30 seconds
Biocompatibility and biodegradability
Accelerates wound healing
Antibacterial and wound healing properties
How does it work?
Two mechanisms of blood stop
Stimulation of plasma and platelet coagulation factors
Matrix for the formation of blood cell membranes
Comparison with competitors
Preparing for use 10 minutes
Stop bleeding within 30 seconds
Stored in the refrigerator Stored in normal conditions
Cost price 20 $ Cost price 1 $
Modern hemostatic
Comparison with competitors
Stop bleeding 2-3 minutes
Stop bleeding within 30 seconds
Acidic pH, traumatize
neutral pH,Speed up wound healing
Swells in wound,desirable to remove
Do not squeeze tissue,no need to remove
Current project status
Development status
• Created prototypes of the gel• Conducted preclinical trials
Publications and patents
• Production secret (know-how) registered
• Patent-pending
Business development
• Organized company (Tectum LLC) • Win in START program (FASIE)• Searching investor / partner
Team
Dr. Alexander Koryagin
Doctor of since (in biology), professor at the plant and animal physiology chair of UNN’s Department of Biology
Dr. Irina Mukhina
Doctor of since (in biology), professor
Developers
Mikhail Gorshenin, CEOManagement, promotion
Management
Experts
Konstantin Pigalov
Consultant, financial analysis, UNN TCC PoC
Kendrick WhiteVice Rector for Innovation Activity, UNN; CEO, UNN Technology Commercialization Center (TCC)
Dr. Larissa Smirnova, CTO
Doctor of since (in chemistry), professor, over 200 scientific publications
Alla Mochalova
Ph.D. in chemistry, associate professor at UNN’s Department of Chemistry
